Monograph Modernization Initiative Looks To Close OTC Quality Loopholes
This article was originally published in The Tan Sheet
Executive Summary
A collaboration among industry, FDA and U.S. Pharmacopeia aims to address what FDA sees as a lack of insight into the quality and purity of OTC monograph drugs